mRNA therapy is one way to deliver the correct genetic instructions to cells, which would allow them to make functional CFTR protein regardless of an individual’s CF mutations.
Site Search
This award is part of the Cystic Fibrosis Foundation’s Physician Scientist Training Program and is designed to introduce residents to cystic fibrosis research with the goal to develop and maintain interest in a career in CF research or as a CF care provider.
This award program is intended to fund training for physicians interested in developing expertise in the endocrinologic care of patients with cystic fibrosis.
Cystic fibrosis is caused by mutations in both copies of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Scientists are examining whether it is possible to correct the mutations through a process called gene editing.
Check your award letter for reporting requirements and due dates.
This program is intended to offer eligible awardees assistance with student loan payments for educational loans acquired in the pursuit of a graduate-level degree.
A diverse group of talented academic investigators leads the cystic fibrosis research community. The Cystic Fibrosis Foundation is pleased to support these investigators through a variety of opportunities.
The Cystic Fibrosis Foundation is aware that many labs and clinical studies have been impacted by the recent response to COVID-19. It is the CF Foundation's intention to work with funding applicants and CF Foundation-funded investigators to minimize the effects of the pandemic on research that is critical to advancing the mission of the Foundation.
Awards for the Infection Research Initiative will support proposals for basic or
This program is intended to promote the role of physical therapy within the cystic fibrosis care team to screen for, prevent, and treat musculoskeletal, cardiovascular, and